
The scrip opened at Rs 694.45 and touched an intraday high and low of Rs 694.45 and Rs 681.75, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 660.1.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 40212.97 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 6038.5 crore for the quarter ended 30-Sep-2021, up 4.41 per cent from previous quarter's Rs 5783.29 crore and up 7.63 per cent from the year-ago quarter's Rs 6537.19 crore.
The net profit for latest quarter stood at Rs 696.99 crore, down 13.55 per cent from the corresponding quarter last year.
As of 30-Sep-2021, DIIs held 9.28 per cent stake in the company, while foreign institutional investors held 23.41 per cent and the promoters 51.83 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 7.71 and a price-to-book ratio of 2.36. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Pick the best companies to invest
BECOME AN ETPRIME MEMBERDownload The Economic Times News App to get Daily Market Updates & Live Business News.